Broermann Medical Innovation Award 2026 Laureates
– Prof. Richard D. DiMarch
– Prof. Svetlana Mojsov
– Prof. Dr. med. Dr. h.c. Matthias Tschöp
Together, their pioneering discoveries have transformed our understanding of metabolism and laid the scientific foundation for a new generation of therapies for type 2 diabetes & obesity.
From the discovery of the biologically active hormone GLP-1 to the development of innovative multi-agonist therapies, their research has fundamentally changed how these diseases are treated – improving the lives of millions of patients worldwide and opening new possibilities for the future of metabolic medicine.
Congratulations to this exceptional trio of scientists whose vision, perseverance, and innovation continue to shape the future of medicine.

